Category Archives: Dermatology

Rx Dermatology Topical Drug Delivery Market

The Rx dermatology topical drug delivery market is expected to witness market growth at a rate of 4.5% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Rx dermatology topical drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rapid advancements in the healthcare sector globally is escalating the growth of Rx dermatology topical drug delivery market.

Request a Sample to obtain authentic analysis and Comprehensive market insights at - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rx-dermatology-topical-drug-delivery-market

The research provides information on the most accurate revenue predictions for the overall market and its sectors in order to help market leaders and new entrants. The purpose of this study is to better understand the competitive environment so that stakeholders can build appropriate go-to-market strategies. The market size, characteristics, and growth of the Rx Dermatology Topical Drug Delivery industry are broken down in this report by type, application, and consumption area. Additionally, the effectiveness of key market segments, such as cost of manufacturing, dispatch, application, volume of usage, and arrangement, is evaluated.

The widespread Rx Dermatology Topical Drug Delivery report has been built with the appropriate expertises that utilize established and unswerving tools and techniques such as SWOT analysis and Porter's Five Forces analysis to conduct the research study. To attain knowhow of market landscape, brand awareness, latest trends, possible future issues, industry trends and customer behaviour, this premium market research report is very crucial. The report also identifies and analyses the intensifying trends along with major drivers, challenges and opportunities in the market. An excellent Rx Dermatology Topical Drug Delivery market report is a source of information about Healthcare industry which puts forth current and upcoming technical and financial details of the industry to 2029.

Competitive Outlook:

The report also includes company profiles, revenue sharing, and SWOT analysis of the key participants in the Rx Dermatology Topical Drug Delivery Market. You may keep one step ahead of the competition by using the Rx Dermatology Topical Drug Delivery industry research, which provides a complete assessment of the crucial factors that are changing. The drivers, restraints, weaknesses, opportunities, and threats in the global market can all be found using these market measurement techniques.

The market size, revenue generated from the sales and technologies by various application segments are properly evaluated in the large scale Rx Dermatology Topical Drug Delivery market survey report. The market research report includes a thorough analysis of the market drivers, restraints, threats, and opportunities while it also addresses the lucrative investment options for the market players in the coming years. Estimates at a global as well as regional level are offered by the analysts. The industry report compiles comprehensive intelligence studies that explore almost every aspect of the global market. The data and information is extensively researched and analyzed in the global Rx Dermatology Topical Drug Delivery business report to direct market players to improve their business planning and ensure long-term success.

Key companies operating in the market are:

Galderma Laboratories, L.P.Hisamitsu Pharmaceutical Co., Inc.Pfizer Inc.LEO Pharma A/SGlaxoSmithKline plc.ALLERGANBayer AG3MBausch Health Companies Inc.The Lubrizol CorporationCipla Inc.Kaken Pharmaceutical Co., Ltd.

Market Overview:

This market study has all the data you require to launch or expand your company in this sector. Along with price and emerging market structure, it also provides market drivers, restraints, competition, and regional estimates. The business model, benchmarks, consumer preferences, value proposition, and net profit of an organisation are all fully described. This thorough Rx Dermatology Topical Drug Delivery market analysis also clarifies important methods that support businesses in accurately determining the purchasing patterns of their clients.

Report Coverage:

We offer our reports, which are conducted using a thorough evaluation methodology that places a strong emphasis on supplying accurate information. Our researchers have used a data triangulation technique, which helps us even more in providing precise estimation and thoroughly testing the general market dynamics. Additionally, in order to provide stakeholders and business experts with the most current information, our analysts have been granted admission to various geographically and globally financed registers.

Browse Complete Reports Along with Facts and Figures of Rx Dermatology Topical Drug Delivery Market @ https://www.databridgemarketresearch.com/reports/global-rx-dermatology-topical-drug-delivery-market

Drivers and Restraints:

The Rx Dermatology Topical Drug Delivery market drivers are acknowledged for their aptitude to show how their actions can affect the market's overall expansion over the course of the predicted period. In order to identify potential emerging trends in the industry, a thorough examination of the significance of the driving forces and potential barriers that market participants may encounter in the Rx Dermatology Topical Drug Delivery market is undertaken. The limitations of the Rx Dermatology Topical Drug Delivery market may draw attention to issues that could impede the expansion of the rising market. Businesses should be able to widen their solutions to problems as a result of understanding the negative aspects of the Rx Dermatology Topical Drug Delivery market, which will increase their ability to influence the pessimistic outlook.

Market Opportunities:

In addition to outlining the reasons that have driven and will continue to fuel the industry's growth, the research looks at some of the major market prospects. It takes into account past growth patterns, growth factors, and present and upcoming trends.

Key Reasons to Buy this Report:

Utilize current information gathered by our own researchers. This gives you access to historical and projected data that is analysed to reveal the reasons the Rx Dermatology Topical Drug Delivery industry is changing; this enables you to foresee market changes and preserve a competitive advantage.

The clear graph, succinct analysis, and table style make it easy to get the data you need.

Defines the region and market sector most likely to see rapid growth and market dominance.

A geographical analysis showing the factors influencing the market in each region as well as how the product or service is used there.

Detailed company profiles for the major market players, including executive summaries, corporate insights, product benchmarking, SWOT analysis, and information on recent service/product launches, business expansions, and acquisitions by the companies profiled.

A forecast of the market for the sector's current and upcoming years that takes into consideration recent changes, such as growth prospects, drivers of that growth, and challenges and constraints in both emerging and developed economies.

Provides information on potential future market growth as well as industry knowledge through a Value Chain - Market Dynamics scenario.

TOC in Brief:

1 INTRODUCTION2 MARKET SEGMENTATION3 EXECUTIVE SUMMARY4 PREMIUM INSIGHTS5 REGULATORY FRAMEWORKS

Continued..

Request for the Detailed TOC of This Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-rx-dermatology-topical-drug-delivery-market

What Does This Report Provide:

What will be the size of the markets and the pace of growth in 2029? What is the anticipated rate of growth for the Rx Dermatology Topical Drug Delivery market? How big will the Rx Dermatology Topical Drug Delivery market be during the projection period? What are the main driving factors that have altered the course of the Rx Dermatology Topical Drug Delivery industry? Which key vendors are leading the Rx Dermatology Topical Drug Delivery industry in various regions? How do they beat the competition by using winning strategies? What threats and obstacles are anticipated to impede the development of the Rx Dermatology Topical Drug Delivery sector in various nations? What are the main chances that entrepreneurs can count on for the foreseeable future? What are the key conclusions of the five-point analysis of the Rx Dermatology Topical Drug Delivery market?

A complete overview of the Healthcare industry has been offered via Rx Dermatology Topical Drug Delivery Market document which considers various aspects of product definition, market segmentation, and the existing retailer landscape. This market research report is formulated by using integrated advancements and latest technology to obtain the most excellent results. This market research report encompasses various parameters of the market. These parameters range from industry outlook, currency and pricing, value chain analysis, market overview, premium insights, key insights to the company profile of the key market players. It becomes easy to create sustainable and profitable business strategies by using valuable and actionable market insights included in the winning Rx Dermatology Topical Drug Delivery Market report.

The Global Dermatology EMR Software Market Size, Share and Demand Expected to Increase USD 248.1 Mn By 2032 – EIN News

April 8, 2023 medical

Dermatology EMR Software Market

The Global Dermatology EMR Software Market Size Is Estimated To Be Worth Usd $ 176.4 Mn In 2023 And Is Forecast To A Readjusted Size Of Usd $ 248.1 Mn By 2032

The Global Dermatology EMR Software Market Size Is Estimated To Be Worth Usd $ 176.4 Mn In 2023 And Is Forecast To A Readjusted Size Of Usd $ 248.1 Mn By 2032 With A Cagr Of 3.5% Over The Forecast Period 2023-2032.

The Advancements In Technology Have Revolutionized The Healthcare Industry, And Nowhere Is This More Apparent Than With Dermatology Emr Software. Electronic Medical Record (Emr) Software Has Made It Simpler For Dermatologists To Keep Their Patient Records Organized And Secure. This Makes It Easier For Dermatologists To Access A PatientS Medical History, Document Treatments, And Make Informed Decisions About Care. With An Emr System, Dermatologists Can Save Time On Paperwork While Providing Better Quality Care.

The Dermatology Emr Software Market Is A Rapidly Growing Sector Of The Medical Technology Industry. Recent Advancements In Electronic Medical Record (Emr) Systems Have Enabled Dermatologists To Better Manage Patient Information And Provide Improved Care. With The Demand For High-Quality Dermatology Services On The Rise, The Global Dermatology Emr Software Market Is Projected To Experience Significant Growth Over The Next Five Years. The Global Healthcare Industry Is Rapidly Changing Due To The Development Of Advanced Technology. One Of Those Advancements Is The Use Of Electronic Medical Records (Emr) Software In Dermatology Practices. Dermatology Emr Software Automates And Streamlines Many Processes That Are Traditionally Managed By Paper Or Other Electronic Systems. This Article Will Explore The Market Opportunity For Dermatology Emr Software, Including Its Potential For Cost Savings, Improved Patient Care, And Increased Practice Efficiency.

The Latest Research On The Global Dermatology Emr Software Market Report Covers Forecast And Top To Bottom Analysis On A Worldwide, Country, And Regional Level. The Study Report Provides Historical Information For 2016-2023 Together With A Forecast From 2023 To 2032 Supported By Both Volume And Revenue (Usd Million). The Whole Study Covers The Key Drivers And Restraints Of The Dermatology Emr Software Industry. Especially This Report Included A Unique Section On The Impact Of Covid-19. Also, Dermatology Emr Software Market (By Major Key Players, By Types, By Applications, And Leading Regions) Segments Outlook, Business Opportunities, Competition Scenario, And Futuristic Trends.

Our Analytics Team Has Deliberately Performed Quantitative And Qualitative Assessments Of The Dermatology Emr Software Market Dynamics, Considering A Slew Of Features, Including Market Penetration, Portfolios, End-User Industries, Pricing Structure And The Key Drivers, Restraints, Opportunities, And Challenges Mostly Affecting Dermatology Emr Software Market Growth.

Our Report Will Help You Find What You Looking for. Get a Request Sample PDF Copy Of The Report @https://market.biz/report/global-dermatology-emr-software-market-gm/#requestforsample

This Dermatology EMR Software Market Report Has Provided In-Depth Information On Leading Future Trends, Growth Factors, Consumption, Production Volume, Cagr Value, Attentive Opinions, Margin Of Profit, Price, And Industry-Validated Market Data, Among Other Things, Included Within The Research Report. Especially Individuals And Market Competitors Can Use This Report To Forecast Future Profitability And Make Critical Business Decisions.

Global Dermatology EMR Software Market Segmentation Analysis

The Market Research Report Includes Information On Dermatology EMR Software Market Regions And Nations. Estimates Are Made For Deals Volume, Mass Production, Consumption, Imports, And Exports. Product Type, Function, End-Use, And Landscape Are The Major Industry Segments. This Study Explores Each Of The Major Parts And Each Of the Sub-Segments In An Order To Completely Comprehend The Market.

Global Dermatology EMR Software Market By Type

The Research Report Analyzes Essential Elements Like Production, Revenue, Price, Size, Advancement, Future Forecast, And Market Rate Of Growth Of Each Type, Primarily Split Into

Cloud Based On Premise

Global Dermatology EMR Software Market By Application

The Research Report Analysis The Market Segmentation, Regional Analysis, Manufacturer Overview, And Prime Applications/End Users:

Hospital Clinic Private

Global Dermatology EMR Software Market Competitor Overview

AdvancedMD DrChrono EHR athenahealth EHR Kareo Clinical EHR PrognoCIS by Bizmatics Compulink Healthcare Solutions Practice Fusion ChARM EHR Modernizing Medicine MDConnection patientNOW Greenway Health NovoClinical eClinicalWorks Nextech Harmony e/Notes TotalMD Advanced Data Systems

Regional AnalysisDermatology EMR Software Market

The Global Dermatology EMR Software Market Report Also Encompasses The Regional Analysis To Offer The Complete Regional Development Status. Additionally, The Report Also Provides Necessary Recommendations And Suggestions For The Dermatology EMR Software Market Players So As To Attain A Competitive Edge In Various Regions. It Also Provides Market Size And Forecast Estimates From the Year 2023 To 2032 With Reference To Five Major Regions,

North America Europe Asia Pacific Latin America The Middle East and Africa

Buy This Premium Report @:

https://market.biz/checkout/?reportId=572427&type=Single%20User

Covid-19 Impact Analysis

Along With The Unique Coronavirus (Covid-19), Problem Expands Around The World, We Regularly Analyze Dermatology EMR Software Market Shifts And Customer Behavior. We Also Consider The Consequences Of The Epidemic While Forecasting Present-Day Industry Trends And estimates. This Material May Be Useful To Industry Partakers Who Are Putting Together Strategies For Epidemic-Suchlike Events.

Major Factors Covered Within The Research Report:

1)The Report Provides All The Vital And Accurate Figures Required To Realize a Better Understanding Of The Market Revenue, Share, And Volume.

2)Industry Overview, Market Strategies, Costing Analysis, Competitive Landscape, Consumption Rate, And Import/Export Details.

3)A Complete Detail Of The Growth Rate Over The Forecast Period Is Described In The Dermatology EMR Software Market Report.

4)All The Aspects Including Market Geographical Development Status And Industry Competitiveness Also Are Presented In The Statistical Format.

5)Other Essential Data Including Risks, Opportunities, Latest Developments, Challenges, And Future Scope Of The Market Are Accurately Covered Within The Report.

6)The Report Covers Key Growth Stimulators, Statistical Data, And Business Strategies Which Will Help Market Key Players Take Crucial Business Decisions.

*Key Questions Answered In This Report

1. What's The Total Market Value Of the Dermatology EMR Software Market Report?

2. What's The Impact Of Post Covid-19 Scenario On the Dermatology EMR Software Industry?

3. How Can I Get Sample Reports/Company Profiles Of Dermatology EMR Software?

4. What Are The Upcoming Trends In Dermatology EMR Software Industry?

5. What Are The Key Strategies Adopted By The Top Players To Increase Their Revenue In Dermatology EMR Software?

6. How Can I Get Sample Reports/Company Profiles Of Dermatology EMR Software?

7. Which Region Is And Can Provide More Business Opportunities For Dermatology EMR Software In the Future?

8. Which Is The Most Influencing Segment Growing In The Dermatology EMR Software Report?

9. Which Are The Key-Matured Markets Growing Within The Dermatology EMR Software Report?

For Inquiry Or Customization On This Dermatology EMR Software Market Report:

https://market.biz/report/global-dermatology-emr-software-market-gm/#inquiry

Our Trending Blogs

https://schlager-news.at

https://portalconstructores.com

Checkout New Related Reports:

Reusable Water Bottles Market Business Outlook, Growth, Revenue, Trends and Forecasts 2032: https://www.einpresswire.com/shareable-preview/YqydR5ZTM2s6FlfjspiBVg

Electric Fuse Market Size, Share, Latest Trends and Analysis, Future Growth Study by 2032: https://www.einpresswire.com/shareable-preview/A8-in60vFMWQLFP_EJCdcQ

Global Tattoo Studio Software Market Competitive Insights, Significant Futuristic Trends and Opportunities 2032 |: https://www.einpresswire.com/shareable-preview/u14IooSXUh6yf1uhYh3u9g

TajPrudour Pvt Lmt+1 8574450045email us here

See original here:

The Global Dermatology EMR Software Market Size, Share and Demand Expected to Increase USD 248.1 Mn By 2032 - EIN News

Dermatology

Its natural for skin to thin with age. Heres how dermatologists say you should care for yours – Fortune

April 8, 2023 medical

While aging signs like wrinkles and varicose veins are well-known, skin thinninga natural progression in which your epidermis becomes fragilegets discussed far less often. While this skin condition happens naturally with time, particularly for people of lighter skin tones, its effects can be painful and stigmatizing.

Thinning results in the skin becoming more transparent and more delicate, almost like tissuepaper. You may notice bruising more easily as a result of collagen loss around blood vessels, explains medical and cosmetic dermatologist Dr. Azadeh Shirazi. This is particularly evident on the backs of the hands and forearms, a condition called actinic purpura.

Because your skin is literally thinner, it can also tear more easily if you run into something sharp or scratch yourself with long fingernails, adds dermatologist Dr. Aanand Geria, of Geria Dermatology in New Jersey. If you have thin skin and youre prone to getting tears, then you are at risk for getting infections, he says. And the older you are, the less well your body fights off infections, and you could be in serious trouble.

Beyond the physical effects of skin thinning, the appearance of this skin condition can also affect mental well-being. People are embarrassed because they have black and blues all over their arms. These are people who are typically used to wearing skirts and short-sleeve shorts, and now they feel embarrassed to wear that stuff, says Geria, adding that many of his older patients feel this way despite the fact that skin thinning is a normal part of aging.

Skin thinning happens primarily because of a loss of two essential skin proteins, collagen and elastin, explains Geria. Collagen provides structure and support to the skin, while elastin provides elasticity. For example, people at younger ages who pull their skin away from their body will see it snap back into shape quickly. However, over time, as your elastin levels drop, it will take the skin longer to bounce back. That loss of elastin is largely sun-induced but alsoto a certain degreeis due to chronological aging, says Geria.

Loss of elastin and collagen is primarily due to U.V. radiation, or frequent exposure to the sun without protection in the form of sunscreen, hats, or long-sleeve shirts. We tend to see [skin thinning] more so in the areas that have been exposed to sun. For example, youll see thin skin on the top of your hands and the top of your forearms, more so than you would see on your belly, explains Geria.

Apart from exposure to the sun, your genetics and the amount of melanin in your skin will also influence skin thinning. Melanin, to a certain degree, does act like a low-grade skin protectant, explains Geria. So when we see thinning of the skin, that is particularly affecting people who have lighter skin. They dont have that melanin that protects them from the sun rays.

Both Geria and Shirazi agree that limiting exposure to sunlightand wearing proper sun protection when you do go outsideis the number one way to care for your skin at every stage of life. Limiting sun exposure and practicing sun protection is one of the most important ways to preserve the quality of your skin, says Shirazi. Make sure youre wearing SPF daily (even if youre working inside), sporting a hat, and limiting your exposure to sunlight.

Lifestyle factorssuch as diet and exercisemay also improve the health of your bodys largest organ. Scientists believe that when you exercise, muscles release myokines, IL-15 specifically, that may have an antiaging effect on the skin, says Shirazi. Exercise also enhances blood flow and oxygen to the skin, and when you sweat, your pores expel oil and dirt, leaving you with a healthy workout glow. Even moderate exercise can positively affect the health of your skin.

If youre already experiencing thinning skin, its still important to wear sunscreen and hats and limit your exposure to sunlight to prevent your skin from becoming even more delicate.

You should also be mindful of how you dress. Your risk of getting tears in your skin is more likely if youre wearing short-sleeve shirts and shorts. So if you wear items that cover your skin, youre gonna get that extra layer of protection so that if you run into a sharp corner of a table, its not going to tear a chunk of your skin out, says Geria. You should also consider keeping your nails short, so they cant catch in your skin.

From a skin-care standpoint, Shirazi has a few recommendations that will help strengthen your skin barrier. Using retinol-based creams help stimulate the production of collagen and hyaluronic acid, preserve the breakdown of viral skin structures, and boost circulation, she says. Shirazi also recommends trying products that contain vitamin C, which plays a role in collagen synthesis, as well as products with CoQ10, an antioxidant that positively influences the age-related cellular metabolism, she says.

You may also consider visiting a dermatologist or a cosmetic dermatologist who can make specific recommendations based on where your skin shows the most signs of thinning. For example, a skin specialist may recommend fillers that have bio-stimulative effects thathelp boost collagen production in targeted areas such as the chest, neck, and arms, Geria explains.

While youre dealing with your thinning skin, also keep in mind that youre not alone. No matter how well youve protected yourself from sun damage and taken care of your body, this part of aging is almost universaland countless other people are going through the same experience.

See the article here:

Its natural for skin to thin with age. Heres how dermatologists say you should care for yours - Fortune

Dermatology

Expert Perspectives on the Role of Interdisciplinary Care in BCC – Dermatology Times

April 8, 2023 medical

2 Minute Drill

Around the Practice

Between The Lines

Case Based Peer Perspective

Dermview

Dermview: Vitiligo

Editorial Board News

Expert Interviews

Expert Perspectives

Frontline Forum

Inside the Clinic

Medical World News

Podcasts

Readout360

Recognize and Refer

Viewpoints

Webinars

View post:

Expert Perspectives on the Role of Interdisciplinary Care in BCC - Dermatology Times

Dermatology

Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand … – Mount Sinai

April 8, 2023 medical

The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease. As a recognized leader in research for skin biology and skin diseases, Mount Sinai will also become an incubator for future biomedical leaders in the field as a result of this program.

Traditional skin biology often focuses on the most obvious cells of the skin, keratinocytes, which form the structure of the epidermis and are essential for skin repair. The Systems Skin Biology program will take an interconnected approach based on the premise that neurons, immune cells, and blood vessels are just as much skin biology as traditional skin cells. Mount Sinai researchers have previously discovered new treatments for itch by studying the intersection of nerves and immune cells, and believe future studies through the Systems Skin Biology program will uncover understandings about wound repair, cancer, hair loss, vitiligo, and acne.

Science and medicine are rapidly evolving, and thus, the training itself must adapt, said co-Principal Investigator Brian S. Kim, MD, MTR, FAAD, Vice Chair of Research and Director of the Mark Lebwohl Center for Neuroinflammation and Sensation at Icahn Mount Sinai. This T32 program is truly unique in that it moves away from focusing on only one discipline, but embraces interdisciplinary training across two traditionally disparate fieldssuch as neuroscience and immunologyby using the skin and associated diseases as a model paradigm.

Dr. Kim, a renowned physician-researcher in chronic itch and inflammatory skin conditions, said the grant (number 1T32AR082315-01) will initially fund two predoctoral fellows or physician-scientists and two postdoctoral fellows or physician-scientists. It will facilitate the training of students toward PhD and/or MD/PhD degrees in intersectional skin biology, as well as training scientists and clinicians with advanced degrees to become independently funded principal investigators. In addition to dermatology, the research training program in Systems Skin Biology will include expertise drawn from across the Health System, including skin biology, immunology, neuroscience, epithelial biology, translational medicine, and stem cell biology.

This training grant will be particularly helpful for pre- and postdoctoral fellows and dermatology residents interested in bringing a new angle and new approaches to skin research, said co-Principal Investigator Sarah E. Millar, PhD, Director of the Black Family Stem Cell Institute and Senior Associate Dean for Basic Research at Icahn Mount Sinai. After training in diverse labs across Mount Sinais campus, they will be able to apply those new skills to uncover novel mechanisms in skin biology and diseases.

This T32 program is one of many steps toward our Department becoming the epicenter of innovation and a world leader in dermatology, as well as in training the future leaders and key opinion thought leaders in dermatology, said Emma Guttman-Yassky, MD, PhD, Waldman Professor of Dermatology and Immunology at Icahn Mount Sinai and Chair of Dermatology at the Mount Sinai Health System. In addition to bringing recognition of the breadth of institutional excellence in cutaneous diseases and skin biology at Mount Sinai, this training program will have an indelible impact on the future of dermatology and dermatology research for decades to come.

Mount Sinai continues to be a leader in the field of skin biology throughout New York City and the tri-state region. In 2021, the Health System established a Skin Biology and Diseases Resource-based Centerthen one of only six nationwide supported by a NIAMS grant. The Center uses technical innovations, high-end infrastructure, and computing power available at Mount Sinai to advance and support skin research; it also embeds experts in gene editing, genomics, and bioinformatics within skin research labs to break down interdisciplinary communication barriers.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 44 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, and gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and masters degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. In addition, more than 535 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinais technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into health care products and services that benefit the public.

Icahn Mount Sinais commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the Schools programs. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinais location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

-------------------------------------------------------

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

Originally posted here:

Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand ... - Mount Sinai

Dermatology

CU School of Medicine Resident Helped to Create Inclusive … – University of Colorado Anschutz Medical Campus

March 31, 2023 medical

As a medical student interested in a career in dermatology, Nneamaka Ezekwe, MD, quickly realized that the textbooks particularly the collections of images of various skin conditions known as atlases didnt include photos of people with skin like hers.

Kodachrome is the word we use to describe pictures of disease that are used as a supplemental learning aid to trainees, says Ezekwe, now adermatologyresident at theUniversity of Colorado School of Medicine. These atlases have great kodachromes of diseases in lighter skin complexions. Erythema, which means redness of the skin, can be easily perceived in a lighter skin tone but may be harder to perceive and can be a subtle finding in darker skin tones. There is a spectrum of skin tones. My darker complexion is one skin tone, and there are complexions representative of Hispanic Latinos and people from the Middle East you cant box everybody into one bubble and say, This is what it looks like. We need to show the whole spectrum.

After Ezekwe graduated from medical school at the University of Mississippi and began working as a research fellow at the Henry Ford Department of Dermatology in Detroit, Michigan, she was excited to be part of an effort to create a more inclusive atlas that includes kodachromes of such conditions as vitiligo, hidradenitis suppurativa, and sarcoidosis in an array of different skin tones.

We tried to stay away from the conventional skin scale that we use as dermatologists, because it was never meant to categorize skin color. It was only supposed to be used as a scale of how easily people can burn or tan, Ezekwe says. Its not an accurate measurement of your skin complexion or the spectrum of skin colors.

For their book, The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, editors Misty Eleryan, MD, MS, and Adam Friedman, MD, compiled more than650 images of more than 85 commonly seen dermatological conditions in an array of skin tones. Displayed side by side, the images are intended to advance education among health care practitioners and to visually teach them to recognize various skin conditions in different skin tones.

The book was released in August 2021, and the publisher sent a free copy to every trainee in every dermatology department in the country. The editors also created a free online database of inclusive dermatology images to which providers can refer.

As a research fellow, Ezekwe says, she was in the right place at the right time to be picked to work on the atlas project. She was one of the principal photographers who contributed images of various skin conditions to the book.

They picked departments of dermatology across the country that are known to have patients with a plethora of skin colors, she says. Henry Ford is a well-known dermatology department that tends to see a multitude of diverse patients because of its geographic location and the providers who are there. The editors reached out to us and said, Would you be interested in working on this atlas?

"My job was to find the patients in clinic, verify diagnosis with the provider, adequately consent,and take professional, studio-style pictures. From there, we would submit pictures and receive feedback by an in-house medical photographer weekly. We would meet regularly with the editors and advisory council to review cases and provide feedback as needed.

It was surprisingly easy to get patients to participate, she says, as many understood how photos of their conditions could help dermatologists make diagnoses in a population that has barriers to treatment. Many patients from ethnic backgrounds underrepresented in medicine have a distrust of the health care system, Ezekwe says, and many feel they arent treated with respect when they go to see a doctor. Compound those factors with conditions that are more difficult to detect in darker skin, and potentially dangerous skin conditions can get misdiagnosed or never diagnosed at all.

It's fairly easy to get shuffled around in the health care system, and then a diagnosis that could have been made in two months is now delayed to six years, she says. Patients from different ethnic groups want to serve as teachers so that their experience doesnt happen to other patients. I received that comment from many patients when I was taking their pictures.

The Full Spectrum of Dermatology is currently being used in her program at the CU School of Medicine, Ezekwe says, and she hears regularly from residents and other trainees across the country about how useful the atlas has been in their training.

'The Full Spectrum of Dermatology' was released in 2021.

The positive feedback, she says, shows that the atlas is slowly achieving its goal of making dermatology more equitable and inclusive.

Obviously, one atlas cant address disparities of health care in general, she says, but I do think this atlas can help to bridge the gap in helping to train providers to make common diagnoses. Even for primary care doctors, if they were able to pick up even one diagnosis that they didnt know, but they now know because they saw it in a book, that can help that patient, and in certain cases, lower their threshold to refer for further management to a dermatologist.

Turn Biotechnologies Introduces its Dermatology Platform to the … – Yahoo Finance

March 31, 2023 medical

MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that it will for the first time share new data for its revolutionary dermatology platform with the international regenerative aesthetic community.

Vittorio Sebastiano, Turn Biotechnologies co-founder and head of research, will share research data at the Aesthetic and Anti-aging World Congress on Friday.

Evidence-based data showing the global regenerative efficacy of Turn Bio's Epigenetic Reprogramming of Aging (ERA) technology on human skin cells will be shared at the Aesthetic and Anti-aging World Congress, the leading international conference specializing in aesthetic regenerative and anti-aging medicine.

Turn Bio's co-founder and head of research Vittorio Sebastiano, PhD, will provide insights on stem cell exhaustion and discuss how the company's ERA technology can rejuvenate cells and restore cellular function in skin. The workshopwill take place on March 31, from 9 a.m. to 10:30 a.m. CET in the Camille Blanc Auditorium at the Grimaldi Forum in Monaco.

The latest Turn Bio dermatology data will also be discussed in presentations by several dermatology key opinion leaders during scientific sessions chaired by internationally recognized experts in the field.

ABOUT TURN BIOTECHNOLOGIES

Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level and developing transformative drug delivery systems. The company's proprietary mRNA platform technology, ERA (Epigenetic Reprogramming of Aging), restores optimal gene expression by combatting the effects of aging in the epigenome. This restores cells' ability to prevent or treat disease and heal or regenerate tissue. It will help to fight incurable chronic diseases. Its eTurnaDelivery Platform uses unique formulations to precisely deliver cargo to specific organs, tissues, and cell types.

The company is completing pre-clinical research on tailored therapies targeting indications in dermatology and immunology, and developing therapies for ophthalmology, osteo-arthritis, and the muscular system. For more information, see http://www.turn.bio.

Story continues

FOR MORE INFORMATION, CONTACT:

Jim Martinez, rightstorygroupjim@rightstorygroup.comor (312) 543-9026

(PRNewsfoto/Turn Biotechnologies, Inc.)

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/turn-biotechnologies-introduces-its-dermatology-platform-to-the-european-aesthetic-community-at-amwc-301785512.html

SOURCE Turn Biotechnologies, Inc.

Turn Biotechnologies Introduces its Dermatology Platform to the ... - Yahoo Finance

Dermatology

AAD Posters Address Misconceptions, Concerns Regarding … – AJMC.com Managed Markets Network

March 31, 2023 medical

A majority of research has shown that biosimilars are highly similar to their originator product in terms of safety and efficacy. Two posters presented at the American Academy of Dermatology (AAD) annual meeting evaluated misconceptions about biosimilars in the dermatology community and addressed concerns around the use of biosimilars in psoriasis with a review of the data.

The first poster reviewed the biosimilar approval process to clarify misconceptions that dermatologists have about biosimilars.1 Dermatologists have approached biosimilar medicines with caution, the researchers wrote.

A recent Cardinal Health report2 corroborated the sentiment that dermatologists are hesitant to switch to biosimilars. According to the report, only 31% of dermatologists considered themselves very familiar with biosimilars compared with 81% of gastroenterologists, 76% of rheumatologists, and 36% of ophthalmologists. Dermatologists were also the most likely compared with the other specialists to say they were not very familiar (13%).

The authors of the AAD poster used a PubMed search to identify studies on the molecular design, preclinical and clinical testing requirements, and approval processes of biosimilars. They described how the complexity of biologics means that even batches of innovator biologics can vary during preclinical testing.

Biosimilars undergo strict preclinical testing and must demonstrate near-similarity to the current originator product in quality factors such as receptor binding and pharmacokinetics, the researchers explained.

While clinical testing is less stringent for a biosimilar compared with the originator product, the purpose of the clinical testing is to confirm the safety and efficacy of the biosimilar. Then, the use of extrapolation allows for biosimilars to be approved for all indications of the originator product without further testing. As a result, the emphasis of biosimilar product testing is on preclinical rather than clinical testing, the authors noted.

Physicians who recognize that biologics are too complex to duplicate, and who desire indication-specific clinical data on biosimilars, might be satisfied knowing biosimilars provide more evidence of similarity than we have for different batches of the innovator product, they concluded. Regulations that are more stringent for biosimilars than for different batches of innovator products may not be logical.

In the second poster, the researchers addressed concerns about the use of biosimilars approved to treat psoriasis using extrapolated evidence from other diseases.3

The researchers compared efficacy/effectiveness, safety, and drug survival of biosimilars to treat plaque psoriasis with originator products. They used data from 13 randomized controlled trials (RCTs) and 3 cohort studies. Of the RCTs, 10 were for adalimumab, 2 were etanercept, and 1 was infliximab. Of the cohort studies, 1 was adalimumab, 1 was etanercept, and 1 was both etanercept and infliximab.

There were 11 trials that compared biosimilars with the originator in patients who had never been on the originator product (initiators), and 9 trials analyzed switching from the originator product to the biosimilar (switchers). The initiator trials all had similar rates of 75% improvement in Psoriasis Area and Severity Index, as well as similar adverse events (AEs) by week 16 and the switched trials also had similar outcomes by week 52.

One of the cohort studies reported more AEs among the group of adalimumab patients switching from originator to the biosimilar, although the other 2 cohort studies showed no significant differences in safety and effectiveness.

The majority of available evidence suggests similarities between biosimilars and originators, the researchers concluded. Future pharmacovigilance studies are needed to evaluate the long-term, real-world use of biosimilars for psoriasis treatment.

References

1. Patel P, Purvis C, Hamid R, Feldman S. Biosimilars in dermatology: understanding testing and addressing misconceptions. Presented at: AAD Annual Meeting; March 17-21, 2023; New Orleans, LA. Poster 41465. https://eposters.aad.org/abstracts/41465

2. 2023 Biosimilars Report. Cardinal Health. February 22, 2023. Accessed March 28, 2023. https://www.cardinalhealth.com/content/dam/corp/web/documents/Report/cardinal-health-biosimilars-report-2023.pdf

3. Phan DB, Warren RB, Lunt M, Yiu ZZN. Biosimilars in the treatment of psoriasis a systematic review of evidence from randomized controlled trials and real-world data. Presented at: AAD Annual Meeting; March 17-21, 2023; New Orleans, LA. Poster 42621. https://eposters.aad.org/abstracts/42621

Link:

AAD Posters Address Misconceptions, Concerns Regarding ... - AJMC.com Managed Markets Network

Dermatology

5 Perspectives on Laser Treatment in Dermatology – Dermatology Times

March 31, 2023 medical

Interested in finding out what is new, trending, and up-and-coming in the world of laser therapy in dermatology? Review these 5 articles from the Maui Derm Hawaii 2023 conference coverage earlier this year.

/AdobeStock

Suneel Chilukuri, MD, discussed a Maui Derm Hawaii 2023 session called Lasers and Energy Devices Used to Treat Medical Problems Whats New in 2023. In the session, a group of experts, including Chilukuri, discussed using lasers and other similar devices to treat dermatologic conditions such as acne, cutaneous lesions, scars, and pigment disorders.

Lawrence Eichenfield, MD, discussed the use of several laser and laser-based therapies for the treatment of acne vulgaris in adolescents at his Maui Derm Hawaii 2023 session.

Several current laser therapy options for acne include blue light, pulsed dye laser, Nd: YAG (long-pulsed, Q-switched, combination), erbium laser resurfacing therapies, intense pulsed light, photodynamic therapy, solid-state fractional 589/1319 nm laser, and 1726-nm laser systems.

Ilona Frieden, MD, discussed the future of laser treatments in port wine stains at her Maui Derm Hawaii 2023 session.

"Part 3 of my talk relates to a remarkable revolution that happened in medicine. And that's the advent of next-generation sequencing, which allowed us to begin to unravel the genomics of so many disorders including port wine stain birthmarks. That occurred in the past 2 decades, but mostly starting around 2010, Frieden said. What happened with that was that we had really no idea what caused them, we knew it must be some developmental error that caused this process of the blood vessels not forming correctly. But that was about it. We knew the causes of the vast majority of them, we do know the causes, and that was a real revelation.

David Laub, MD, discussed the use of laser treatment in cosmetic procedures in his Maui Derm Hawaii 2023 session Whats My Treatment.

In the session, Laub and a panel of experts discussed several real-world patient cases. Dermatologists in the surgical and aesthetic spaces assessed each case to determine which treatment (energy-based devices, lasers, fillers, injectables, topical medications) would be recommended. Then, the panelists revealed which treatment was used and why.

The second case could be in the same arena pigmentation, where a different colleague will go and maybe treat it with lasers or some other device, the same particular problem so that the audience can get a very strong sense of the different modalities that can be used for a particular problem, whether it be pigmentation, wrinkles, or reversing sun damage, in the form of texture, Laub said.

Suzanne Kilmer, MD, discussed the future of laser and energy-based devices in dermatologic treatment in her Maui Derm Hawaii 2023 session Lasers, Lights, Radiofrequency, Photodynamic Therapy and More.

We also talk about acne and ways to target acne with lasers, that's a booming field right now, Kilmer said. There are new lasers in the 1720 nanometer range that target the sebaceous glands because they have fat in them and that wavelength is absorbed by fat. So that's kind of a big newer one that's coming out.

More here:

5 Perspectives on Laser Treatment in Dermatology - Dermatology Times

Dermatology

Making Connections Between Psychiatry and Dermatology – Psychiatric Times

March 31, 2023 medical

Various studies encounter a psychiatric condition in 1 out of 3 dermatology patients. In collaboration with Dermatology Times, Psychiatric Times connected with George Kroumpouzos, MD, PhD, FAAD, a dermatologist who combines psychodermatology with clinical and cosmetic dermatology in his practice.

In this episode of An Appointment With, Kroumpouzos discusses the connections between psychiatric and dermatologic conditions, as well as the ways psychiatrists and dermatologists can work together to help patients with psychiatric and dermatologic comorbidities.

Dr Kroumpouzos is director of GK Dermatology, a clinical associate professor of dermatology at Brown University, and a professor of dermatology and collaborator at Jundia Medical School in So Paulo, Brazil.He combines clinical, cosmetic, and psychodermatology in his practice.

See the original post:

Making Connections Between Psychiatry and Dermatology - Psychiatric Times